Applying Evidence-Based Medicine to Shared Decision Making: Value of Restricted MeanSurvival Time - 19/12/18
Doi : 10.1016/j.amjmed.2018.07.026
Zachary R. McCaw, AM a, Ariela R. Orkaby, MD, MPH b, c, Lee-Jen Wei, PhD a, Dae Hyun Kim, ScD, MD d, Michael W. Rich, MD e, ⁎ 
a Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA
b Geriatric Research, Education and Clinical Center (GRECC),VA Boston Healthcare System, Boston, MA
c Division of Aging, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
d Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
e Cardiovascular Division, Department of Internal Medicine,Washington University School of Medicine, St Louis, MO.
⁎Requests for reprints should be addressed to Michael W. Rich, MD, Washington University School of Medicine, 660 South Euclid Avenue, CB 8086, St Louis, MO, 63110, mrich@wustl.eduWashington University School of Medicine660 South Euclid Avenue, CB 8086St LouisMO63110
Le texte complet de cet article est disponible en PDF.
| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: ZRM and ARO contributed equally to this work and are co-first authors. DHK and MWR are co-senior authors. All authors had access to the data and a role in writing manuscript. |
© 2019
Publié par Elsevier Masson SAS.
Vol 132 - N° 1
P. 13-15 - janvier 2019 Retour au numéro
Article précédent
- Should Patients Infected with Borrelia burgdorferi No Longer Be Referred to as Having Lyme Disease?
- Gary P. Wormser
- Novel and Emerging Therapeutics for Primary Prevention of Cardiovascular Disease
- Leo F. Buckley, Salvatore Carbone, Ahmed Aldemerdash, Nayyra Fatani, John Fanikos
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?